1-aza-bicyclo[3.3.1]nonanes
    7.
    发明授权
    1-aza-bicyclo[3.3.1]nonanes 有权
    1-氮杂 - 双环[3.3.1]壬烷

    公开(公告)号:US08933090B2

    公开(公告)日:2015-01-13

    申请号:US12907506

    申请日:2010-10-19

    CPC分类号: C07D471/08

    摘要: The present invention relates to 1-aza-bicycloalkyl derivatives of Formula (I); wherein the substituents are as defined in the specification, to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them. Formula (I), wherein A represents O or N(R1); Y represents a group of formula, or wherein the left bond is attached to the A group and the right bond is attached to the R group; R represents a substituted or unsubstituted C5-C10aryl, substituted or unsubstituted hetero-C5-C10aryl, a group N(R1)(R4), or a group N(R2)(CHP3R4); R represent a hydrogen, C1-C4alkyl, or CF3; R2 represents hydrogen, C1-C4alkyl, or CF3; R3 represents hydrogen, C1-C4alkyl, or CF3; R4 represents a substituted or unsubstituted C5-C10 aryl or a substituted or unsubstituted C5-C10heteroaryl; in free base or acid addition salt form.

    摘要翻译: 本发明涉及式(I)的1-氮杂 - 双环烷基衍生物; 其中取代基如本说明书中所定义,其制备方法,它们作为药物的用途以及包含它们的药物组合物。 式(I)其中A表示O或N(R1); Y表示一组式,或其中左键连接至A基团,右键连接至R基团; R代表取代或未取代的C 5 -C 10芳基,取代或未取代的杂-C 5 -C 10芳基,基团N(R 1)(R 4)或基团N(R 2)(CH 3 R 4)。 R代表氢,C1-C4烷基或CF3; R 2表示氢,C 1 -C 4烷基或CF 3; R3表示氢,C1-C4烷基或CF3; R4表示取代或未取代的C5-C10芳基或取代或未取代的C5-C10杂芳基; 在游离碱或酸加成盐形式。

    1-AZA-BICYCLO[3.3.1]NONANES
    8.
    发明申请
    1-AZA-BICYCLO[3.3.1]NONANES 审中-公开
    1-AZA-BICYCLO [3.3.1] NONANES

    公开(公告)号:US20110034475A1

    公开(公告)日:2011-02-10

    申请号:US12907506

    申请日:2010-10-19

    CPC分类号: C07D471/08

    摘要: The present invention relates to 1-aza-bicycloalkyl derivatives of Formula (I); wherein the substituents are as defined in the specification, to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them. Formula (I), wherein A represents O or N(R1); Y represents a group of formula, or wherein the left bond is attached to the A group and the right bond is attached to the R group; R represents a substituted or unsubstituted C5-C10aryl, substituted or unsubstituted hetero-C5-C10aryl, a group N(R1)(R4), or a group N(R2)(CHP3R4); R represent a hydrogen, C1-C4alkyl, or CF3; R2 represents hydrogen, C1-C4alkyl, or CF3; R3 represents hydrogen, C1-C4alkyl, or CF3; R4 represents a substituted or unsubstituted C5-C10 aryl or a substituted or unsubstituted C5-C10heteroaryl; in free base or acid addition salt form.

    摘要翻译: 本发明涉及式(I)的1-氮杂 - 双环烷基衍生物; 其中取代基如本说明书中所定义,其制备方法,它们作为药物的用途以及包含它们的药物组合物。 式(I)其中A表示O或N(R1); Y表示一组式,或其中左键连接至A基团,右键连接至R基团; R代表取代或未取代的C 5 -C 10芳基,取代或未取代的杂-C 5 -C 10芳基,基团N(R 1)(R 4)或基团N(R 2)(CH 3 R 4)。 R代表氢,C1-C4烷基或CF3; R 2表示氢,C 1 -C 4烷基或CF 3; R3表示氢,C1-C4烷基或CF3; R4表示取代或未取代的C5-C10芳基或取代或未取代的C5-C10杂芳基; 在游离碱或酸加成盐形式。

    ORGANIC COMPOUNDS
    9.
    发明申请
    ORGANIC COMPOUNDS 有权
    有机化合物

    公开(公告)号:US20100184775A1

    公开(公告)日:2010-07-22

    申请号:US12732357

    申请日:2010-03-26

    CPC分类号: C07D471/08 A61K31/429

    摘要: The present invention relates to compounds of formula (I) wherein n represents 0, 1, 2, 3, 4 or 5, R represents independent from each other hydroxyl, cyano, nitro, halogen, alkyl, alkoxy alkylcarbonyl, alkoxycarbonyl, alkylamine, dialkylamine, alkylcarbonylamine, alkylcarbamate Y represents one of the following groups: (Ia) in free base or acid addition salt form, to processes for their production, to pharmaceutical compositions comprising them and their use in the manufacture of a medicament for the treatment and/or delay of progression of psychotic and neurodegenerative disorders.

    摘要翻译: 本发明涉及式(I)化合物,其中n表示0,1,2,3,4或5,R表示彼此独立的羟基,氰基,硝基,卤素,烷基,烷氧基烷基羰基,烷氧基羰基,烷基胺,二烷基胺 ,烷基羰基胺,烷基氨基甲酸酯Y代表以下基团之一:游离碱或酸加成盐形式的(Ia),其制备方法,包含它们的药物组合物及其在制备用于治疗和/或 延迟精神病和神经退行性疾病的进展。